ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.505,70
0,47%
S&P 500
6.018,51
0,40%
Dow Jones
44.429,35
0,02%
Euro vs US Dollar
1,03707
0,42%
Bitcoin
99.199,16
-2,21%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Embecta Corporation (EMBC) Börsenkurse

Embecta Corporation

Embecta Corporation (EMBC)

NASDAQ
17,96
0,01
( 0,06% )
Aktualisiert: 18:20:27
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
17,96
Gebot
17,92
Fragen
17,96
Volumen
69.775
17,74 Tagesbereich 17,9777
9,925 52-Wochen-Bereich 21,48
Marktkapitalisierung
1,044B
Handelsende
17,95
Handelsbeginn
17,84
Letzte Trade
10
@
17.96
Letzter Handelszeitpunkt
18:20:27
Finanzvolumen
US$ 1.244.161
VWAP
17,831
Durchschnittliches Volumen (3 Mio.)
428.713
Ausgegebene Aktien
58.130.561
Dividendenrendite
3.34%
Kurs-Gewinn-Verhältnis
13,23
Gewinn pro Aktie (EPS)
1,35
Erlöse
1,12B
Nettogewinn
78,3M

Über Embecta Corporation

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Website
www.embecta.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Embecta Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker EMBC. The last closing price for Embecta was US$17,95. Over the last year, Embecta shares have traded in a share price range of US$ 9,925 to US$ 21,48.

Embecta currently has 58.130.561 shares in issue. The market capitalisation of Embecta is US$1,04 billion. Embecta has a price to earnings ratio (PE ratio) of 13.23.

EMBC Neueste Nachrichten

Weitere Nachrichten

embecta to Report Fiscal First Quarter 2025 Financial Results

PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference...

23 Januar 2025
GlobeNewswire Inc.

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco...

19 Dezember 2024
GlobeNewswire Inc.

Form ARS - Annual Report to Security Holders

19 Dezember 2024
Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

19 Dezember 2024
Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements

19 Dezember 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

11 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 Dezember 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

04 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

02 Dezember 2024
Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

29 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.45-7.470376094819.4119.56517.4426206918.23193102CS
4-2.57-12.518265952320.5321.117.4434035619.10509706CS
122.2914.613911933615.6721.4813.0542871318.88952528CS
263.5924.982602644414.3721.4812.4238947716.76821954CS
520.965.647058823531721.489.92541249414.96183309CS
156-14.4-44.49938195332.3636.649.92561073923.54092857CS
260-14.4-44.49938195332.3636.649.92561073923.54092857CS

EMBC - Frequently Asked Questions (FAQ)

What is the current Embecta share price?
The current share price of Embecta is US$ 17,96
How many Embecta shares are in issue?
Embecta has 58.130.561 shares in issue
What is the market cap of Embecta?
The market capitalisation of Embecta is USD 1,04B
What is the 1 year trading range for Embecta share price?
Embecta has traded in the range of US$ 9,925 to US$ 21,48 during the past year
What is the PE ratio of Embecta?
The price to earnings ratio of Embecta is 13,23
What is the cash to sales ratio of Embecta?
The cash to sales ratio of Embecta is 0,92
What is the reporting currency for Embecta?
Embecta reports financial results in USD
What is the latest annual turnover for Embecta?
The latest annual turnover of Embecta is USD 1,12B
What is the latest annual profit for Embecta?
The latest annual profit of Embecta is USD 78,3M
What is the registered address of Embecta?
The registered address for Embecta is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Embecta website address?
The website address for Embecta is www.embecta.com
Which industry sector does Embecta operate in?
Embecta operates in the SURGICAL,MED INSTR,APPARATUS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CAPTCaptiVision Inc
US$ 1,25
(184,74%)
182,87M
LTRYLottery com Inc
US$ 0,5105
(63,62%)
8,87M
QNTMQuantum Biopharma Ltd
US$ 5,105
(60,53%)
43,05M
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 223,93
(44,18%)
1,21M
PLTUDirexion DAily PLTR Bull 2X Shares
US$ 47,48
(43,92%)
1,72M
OMGAOmega Therapeutics Inc
US$ 0,2401
(-49,89%)
3,39M
VIRXViracta Therapeutics Inc
US$ 0,0517
(-33,55%)
3,99M
UPCUniverse Pharmaceuticals Inc
US$ 0,278
(-33,40%)
1,37M
CSAICloudastructure Inc
US$ 14,30
(-24,74%)
27,02k
SDSTStardust Power Inc
US$ 0,7903
(-23,27%)
3,28M
CAPTCaptiVision Inc
US$ 1,25
(184,74%)
182,89M
PLTRPalantir Technologies Inc
US$ 102,49
(22,39%)
146,6M
NVDANVIDIA Corporation
US$ 118,7499
(1,79%)
131,7M
RGTIRigetti Computing Inc
US$ 13,765
(2,19%)
114,53M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,160299
(-17,75%)
89,96M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
EMBC
Embecta
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten